Valid Ghana · FDA Ghana

TYPHIBEV VACCINE (TYPHOID CONJUGATE (MONOVALENT)) SOLUTION FOR INJECTION

TYPHOID CONJUGATE (MONOVALENT)

FDA/HVC/255-04013 TYPHOID CONJUGATE (MONOVALENT)

What it does

Conjugate is a type of medicine that may be used for various health conditions.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/HVC/255-04013
Registration date
2025-04-28
Expiry date
2030-05-01
Status
Valid
Active ingredient
TYPHOID CONJUGATE (MONOVALENT)
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Biological E.
Country of origin
INDIA

Source: Food and Drugs Authority · fetched 2026-06-16 04:00:15 · updated 2026-09-29 04:00:08

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About conjugate

Conjugate is a type of medicine that may be used for various health conditions.

How it works

The exact way conjugate works may depend on the specific condition it is being used for.

Who it's for

Conjugate may be suitable for individuals with certain health issues as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About typhoid

Typhoid is an infectious disease caused by the bacteria Salmonella typhi, leading to fever and gastrointestinal symptoms.

What it treats

  • typhoid fever
  • enteric fever

How it works

Typhoid is treated with antibiotics that kill the bacteria causing the infection.

Who it's for

Typhoid treatment is for individuals diagnosed with typhoid fever or those at risk of infection.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: conjugate

Conjugates are a class of compounds formed by the chemical linkage of two or more substances, often used in pharmacology to enhance the properties of a drug, such as its solubility, stability, and targeted delivery. Conjugation can occur with various molecules, including proteins, carbohydrates, and nucleic acids, leading to conjugate drugs that can improve therapeutic efficacy and reduce side effects.

Indications

  • Cancer therapy
  • Autoimmune diseases
  • Infectious diseases
  • Targeted drug delivery systems
  • Vaccination strategies

Dosage

Children: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.

Adults: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.

Mechanism of action

The mechanism of action of conjugate drugs varies widely depending on the specific substances involved in the conjugation. Generally, conjugation can facilitate drug uptake into cells, enhance bioavailability, and alter the pharmacokinetics of the active drug. Some conjugates are designed to target specific receptors or tissues, thereby improving the specificity and efficacy of the therapeutic effect.

Pharmacodynamics

Pharmacodynamics of conjugate drugs is largely dependent on the nature of the conjugated entities. They may exhibit altered binding affinities, modified distribution profiles, and varying degrees of activity compared to their non-conjugated counterparts. The therapeutic effect could be amplified or diminished based on the conjugation strategy employed, with implications for potency and duration of action.

Pharmacokinetics

Pharmacokinetics of conjugate drugs is influenced by the characteristics of both the parent drug and the conjugated moiety. Factors such as absorption, distribution, metabolism, and excretion (ADME) can be significantly altered. Conjugates may exhibit improved solubility and permeability, leading to enhanced absorption and bioavailability. Metabolic pathways may also be modified, potentially altering the half-life and clearance rates of the drug.

Pregnancy

The safety of conjugate vaccines during pregnancy has not been fully established. Use during pregnancy should be based on the benefit-to-risk assessment.

Breast-feeding

Conjugate vaccines are generally considered safe during breastfeeding. Vaccination can be beneficial for the infant when the mother is immunized.

Storage

Conjugate vaccines should be stored in a refrigerator at 2-8 degrees Celsius and protected from light. Do not freeze.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: typhoid

Typhoid fever is a systemic infection caused by the bacterium Salmonella enterica serotype Typhi. It is typically transmitted through contaminated food and water, leading to gastrointestinal symptoms, fever, and systemic illness. Treatment usually involves antibiotics to eliminate the bacteria and supportive care to manage symptoms.

Indications

  • Typhoid fever
  • Enteric fever
  • Salmonella infections

Dosage

Children: Refer to specific antibiotic guidelines for dosing, as it varies based on the antibiotic used and local resistance patterns.

Adults: Refer to specific antibiotic guidelines for dosing, as it varies based on the antibiotic used and local resistance patterns.

Mechanism of action

Antibiotics used to treat typhoid fever, such as ciprofloxacin and azithromycin, inhibit bacterial DNA gyrase or protein synthesis, respectively, leading to bacterial cell death. These mechanisms target critical bacterial processes, preventing replication and function.

Pharmacodynamics

The pharmacodynamic effects of antibiotics against Salmonella Typhi include bactericidal action, which reduces the bacterial load and alleviates the symptoms of infection. The choice of antibiotic may depend on local resistance patterns, as some strains have developed resistance to commonly used drugs.

Pharmacokinetics

The pharmacokinetics of antibiotics vary. For example, ciprofloxacin is well absorbed orally, with peak plasma concentrations occurring within 1-2 hours. It has a volume of distribution of approximately 2-3 L/kg and is primarily excreted through urine. Azithromycin, on the other hand, has excellent tissue penetration and a long half-life, allowing for once-daily dosing.

Adverse effects

  • Gastrointestinal disturbances
  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • Rash
  • Fatigue

Precautions

  • Use with caution in patients with a history of gastrointestinal disease
  • Monitor for potential drug interactions
  • Consider risk of antibiotic resistance

Pregnancy

Consult a healthcare provider before use, as safety during pregnancy is not well established.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

South Africa 1 product